Veradermics
MANE
110.95
+1.99
+1.83%
Veradermics
US · MANE
#2148 by market cap
Listed 2026
110.95
+1.99
+1.83%
Live - 5344 symbols - heartbeat 128s ago
· 2026-10-08 07:00
Pre-market
111.10
+0.14%
After-hours
110.95
0.00%
Overnight
110.95
0.00%
- Market cap
- 4.64B
- P/E (TTM)i
- -44.45
- P/Bi
- 5.70
- EPSi
- -2.23
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on MANE?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 5 analysts
Buy
Avg price target
169.20 +52.5%
Price target rangecurrent 110.95
Low160.00
Avg169.20
High182.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-15 | Citi | -- | BUY | 160.00 |
| 2026-09-10 | Citi | -- | BUY | 160.00 |
| 2026-09-08 | Jefferies | -- | BUY | 182.00 |
| 2026-08-13 | Citi | -- | BUY | 160.00 |
| 2026-08-12 | Needham | -- | BUY | 164.00 |
| 2026-08-11 | LifeSci Capital | -- | BUY | 170.00 |
| 2026-07-18 | LifeSci Capital | -- | BUY | 170.00 |
| 2026-07-16 | Citi | -- | BUY | 160.00 |
| 2026-07-15 | LifeSci Capital | -- | BUY | 170.00 |
| 2026-07-15 | Needham | -- | BUY | 164.00 |
| 2026-07-15 | B. Riley Securities | -- | BUY | 170.00 |
| 2026-06-22 | Citi | -- | BUY | 135.00 |
| 2026-06-18 | Citi | -- | BUY | 135.00 |
| 2026-06-16 | LifeSci Capital | -- | BUY | 135.00 |
| 2026-06-02 | Needham | -- | BUY | 136.00 |
| 2026-05-18 | Citi | -- | BUY | 135.00 |
| 2026-05-14 | Jefferies | -- | BUY | 138.00 |
| 2026-05-01 | Citi | -- | BUY | 120.00 |
| 2026-04-28 | Citi | -- | BUY | 120.00 |
| 2026-04-27 | Citi | -- | BUY | 120.00 |
| 2026-04-13 | Citi | -- | BUY | 85.00 |
| 2026-04-10 | Citi | -- | BUY | 85.00 |
| 2026-03-30 | Citi | -- | BUY | 85.00 |
| 2026-03-03 | Citi | -- | BUY | 85.00 |
| 2026-03-02 | Jefferies | -- | BUY | 75.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Quote time 2026-10-08 07:00:21 · For reference only, not investment advice and not tailored to your situation.